CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore Immatics Biotechnologies's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 7, 2025
Patent NumberGrant DateTitleTotal Oppositions
Aug 28, 2024Sorting With Counter Selection Using Sequence Similar Peptides1
Sep 7, 2022Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Hepatocellular Carcinoma (Hcc) And Other Cancers1

Top competitors of Immatics Biotechnologies

List of top competitors of Immatics Biotechnologies based on patent oppositions.